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esponsibility of InstAbstract P2X1 receptors and adrenoceptors are mainly responsible for vasoconstriction in a
variety of blood vessels. However, previous studies have shown that a,b-methylene adenosine
50-triphosphate (a,b-MeATP), a stable analogue of ATP, can induce both pressor and depressor
responses in laboratory animals. In this study, the effects of increasing intravenous doses of a,b-
MeATP and noradrenaline (NA) (0–30 nmol/kg) administered at 20 min intervals on systolic
(SBP), diastolic (DBP) and mean (MBP) blood pressure in groups of anesthetized mice (n¼6) were
compared. Both a,b-MeATP and NA caused transient, dose-dependent increases in SBP, DBP and
MBP but the effect of a,b-MeATP was more rapid and signiﬁcantly larger at doses of 10 and
30 nmol/kg (Po0.01). At the dose of 30 nmol/kg, a,b-MeATP increased SBP, DBP and MBP by
65.877.0, 65.775.0 and 65.775.5 mmHg, respectively, compared to increases of 36.874.6,
33.374.9 and 34.574.7 mmHg, respectively, produced by NA. These results indicate P2X1
receptors play an important role in BP regulation although purinergic vasoconstriction alone
may not explain the more potent pressor response to a,b-MeATP in the anesthetized mouse.
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Noradrenaline (NA) and adenosine 50-triphosphate (ATP) are
known to act as sympathetic co-transmitters in a variety of blood
vessels. In laboratory animals, the neurogenic vasoconstriction
induced by electrical ﬁeld stimulation involves a purinergic
(prazosin-resistant) component and an adrenergic (prazosin-sensi-
tive) component in different types of blood vessels1–4. P2X and
P2Y receptors are widely distributed in the cardiovascular system
and are important for the regulation of vascular tone5. The P2X1
receptor is the principal P2X receptor subtype expressed on most
vascular smooth muscles6 where it mediates purine nucleotide-
induced arterial contraction7,8. Our previous studies showed that
a,b-methylene ATP (a,b-MeATP), a stable analogue of ATP,
evoked at least 80% of the maximal vasoconstriction to NA in the
rat tail artery but only about 40% of it in the rat aorta and
internal carotid, mesenteric and pulmonary arteries9. This indi-
cates that functional P2X1 receptors are more densely distributed
in the rat tail artery and that the P2X1 receptor plays an important
physiological role in maintaining vascular tone.
It has been reported that a,b-MeATP signiﬁcantly inhibits
vasoconstrictive responses to electrical ﬁeld stimulation in the tail
arteries of spontaneously hypertensive rats but not in those of
normal rats10. In addition a,b-MeATP evoked transient constric-
tions of the femoral, tail, uterine and large mesenteric arteries
taken from wild-type mice but not of arteries taken from P2X1
receptor-deﬁcient mice8. However, in anesthetized rats, microinjec-
tion of a,b-MeATP into the subpostremal nucleus tractus solitar-
ius produced a dose-dependent decrease in blood pressure (BP)11
whereas intra-arterial or intravenous (iv) injection of a,b-MeATP
increased BP12,13. Moreover, iv administration of ATP to anesthe-
tized mice caused an obvious decrease in systemic arterial BP14.
The purpose of the study reported here was to observe pressor
responses to NA and a,b-MeATP and to compare the effect of iv
administration of a,b-MeATP and NA on BP in the anesthetized
mouse.2. Materials and methods
2.1. Materials
[-]-Noradrenaline bitartrate (NA) and a,b-MeATP (lithium
salt) were obtained from Sigma Chemical Company and
dissolved in distilled water before use.
2.2. Animals
Male albino KM strain mice (35–40 g, originally derived from
Swiss mice at the Hoffkine Institute, India) were supplied by
the Laboratory Animal Center of Hebei Medical University
(China). Mice were supplied with standard laboratory chow
and water and kept under a 12 h light–dark cycle in the animal
care facility. Use of animals complied with institutional animal
care guidelines and was approved by the local Institutional
Ethics Committee.
2.3. Arterial BP determination
Mice were anesthetized by injection of urethane (1.5 g/kg) and
the trachea catheterized to facilitate breathing and allowdrainage of bronchial secretions. A venoclysis needle (24 G)
ﬁlled with physiological saline containing 350 U/mL heparin
was then inserted into the left common carotid artery for
measurement of SBP, DBP and MBP via a 3-way stopcock
connecting a pressure transducer on PowerLab/8sp. For drug
administration, the tail vein was cannulated using a venoclysis
needle (26 G) ﬁtted with a short silicone tube. Total injection
volume was kept at 60 mL. Room temperature was maintained
at 26–28 1C and an equilibrium time of 20–40 min was allowed
between the surgical procedure and drug application.
2.4. Effects of NA and a,b-MeATP on BP
Two groups of mice (n¼6) were randomly selected and their
baseline values of SBP, DBP and MBP determined. Then at
20 min intervals, the two groups were sequentially adminis-
tered either NA or a,b-MeATP at doses of 1, 3, 10 and
30 nmol/kg and the maximum increases in BP measured15. In
a preliminary experiment in another group of mice (n¼5), two
doses of a,b-MeATP (20 nmol/kg) were administered at a
20 min interval14 to investigate tachyphylaxis in the pressor
response.
2.5. Statistical analysis
Values of BP (mmHg) are given as mean7standard error of
the mean (SEM). Two-way ANOVA was used to evaluate any
differences between dose-response curves. If the F statistic was
signiﬁcant, individual data were compared with their respec-
tive control values using the Bonferroni test. Pressor responses
to the two equal doses of a,b-MeATP in the same mouse were
analyzed using the paired Student t-test. Differences for which
Po0.05 were considered statistically signiﬁcant. The data were
analyzed using GraphPad Prism version 5.00 (San Diego,
CA, USA).3. Results
a,b-MeATP at 20 nmol/kg produced a rapid increase in BP
which reached its peak value within 10 s before subsequently
returning to baseline over 2 min. The second administration of
a,b-MeATP at the same dose after 20 min induced a similar
pressor response to the ﬁrst dose (Fig. 1) with no signiﬁcant
differences in the maximum values of SBP, DBP or MBP
(Fig. 2). In the two groups of mice given either NA or a,b-
MeATP, the baseline values of SBP, DBP and MBP were not
signiﬁcantly different (P40.05, Fig. 3). Administration of NA
or a,b-MeATP at 1, 3, 10 and 30 nmol/kg at 20 min intervals
produced dose-dependent increases in SBP, DBP and MBP
but the increases induced by a,b-MeATP were much greater
than those induced by NA (Po0.01, Fig. 4). Representative
traces for the 30 nmol/kg doses are shown in Fig. 5. The actual
increases in SBP, DBP and MBP produced by a,b-MeATP at
this dose were 65.877.0, 65.775.0 and 65.775.5 mmHg,
respectively, compared with 36.874.6, 33.374.9 and
34.574.7 mmHg for NA.
4. Discussion
In the present study pressor responses to iv administration of
a,b-MeATP and NA were studied in the anesthetized mouse.
Figure 3 Baseline values of SBP, DBP and MBP in two groups
of anesthetized mice prior to intravenous administration of either
a,b-methylene ATP or noradrenaline. Data are mean values with
vertical bars showing SEM (n¼6).
Figure 2 Increases in SBP, DBP and MBP produced by two
equal intravenous doses of a,b-methylene ATP (20 nmol/kg) given
20 min apart to anaesthetized mice. Data are mean values with
vertical bars showing SEM (n¼5).
Figure 1 Representative traces showing the effects of two equal
intravenous doses of a,b-methylene ATP (20 nmol/kg) given
20 min apart on blood pressure (mmHg) in anesthetized mice.
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in BP which for a,b-MeATP developed more rapidly (within
seconds) possibly due to an increase in vascular tone. We also
showed that the response to a,b-MeATP was not subject to
tachyphylaxis.
In a previous study in anesthetized rats, microinjection of
a,b-MeATP into the subpostremal nucleus tractus solitarius
produced a dose-dependent decrease in BP11 indicating the
pressor response to a,b-MeATP involves a peripheral mechan-
ism. Steinmetz et al.13 also studied the pressor response toa,b-MeATP in the anesthetized rat and reported that an
injection of 99 nmol/(kg min) into the jugular vein increased
MBP by 44 mmHg whereas iv administration of AMP, ADP,
and ATP caused obvious decreases in systemic arterial
pressure. No hypotensive response to iv administration of
a,b-MeATP was found in the present study presumably
because a,b-MeATP is stable whereas ATP is rapidly degraded
to AMP, ADP and adenosine.
In the present study, we found that the increase in BP produced
by a,b-MeATP is much greater than that produced by the same
dose of NA (Ea,b-MeATP/ENA equal to 1.90 for a dose of
30 nmol/kg). However, in our previous study of isolated rat
arteries, we found that the maximal vasoconstriction produced
by a,b-MeATP was signiﬁcantly smaller than that produced by
NA at the same concentration9. Thus there are clear differences in
the cardiovascular effects of a,b-MeATP in rat and mouse. The
precise mechanism underlying species difference in the pressor
response to a,b-MeATP has yet to be elucidated.
Since the adrenal medulla plays a relatively important role
in cardiovascular homeostasis in the rat16, it seems likely that
blood-borne catecholamines contribute to maintain systemic
arterial blood pressure at a fairly constant level. Cavalli
et al.15 reported that NA injected into the jugular vein of
conscious mice at 20, 40, 80, 160, 320 and 640 ng/kg induced
a dose-dependent increase in MBP with the highest dose
increasing it by about 35 mmHg. However, due to the
dysrythmic effects of high doses of NA in conscious animals,
they were unable to measure absolute maximal pressor
responses. In the present study in anesthetized mice, the
threshold dose for a pressor response to NA was 1 nmol/kg
(330 ng/kg) and an increase in MBP of 34.574.7 mmHg was
produced by iv administration of NA at 30 nmol/kg (10 mg/
kg), a dose some 15 times higher than the highest dose used
by Cavalli et al.15. It appears therefore that pressor responses
in the conscious mouse are more sensitive than in the
anesthetized mouse.
Figure 4 Effects of sequentially increasing intravenous doses of a,b-methylene ATP and noradrenaline (0–30 nmol/kg) given at 20 min
intervals on (A) systolic, (B) diastolic and (C) mean blood pressure in two groups of anesthetized mice. Data are means7SEM (n¼6).
Po0.01 vs. noradrenaline.
Figure 5 Representative traces showing the effects of equal 30 nmol/kg doses of (A) a,b-methylene ATP and (B) NA on blood pressure
(mmHg) in anesthetized mice.
Lu Li et al.462P2 purinoceptors are present on both peripheral and central
noradrenergic neurons17. Furthermore, in certain cell types or
tissues, AD and ATP release serotonin and can thereby cause
powerful vasoconstriction. The effects of purines may also be
mediated by the release of prostaglandins some of which are
potent vasoactive compounds able to act either directly on
smooth muscle or via the neurogenic vascular regulation. In
addition, endogenous ATP may serve as a fast transmitter
substance in the NTS-mediated mechanism of cardiovascularregulation18. Moreover the P2X receptor-mediated increase in
MBP is sensitive to muscle temperature an increase in which
attenuates the response19. This suggests that vasoactive
purines exert a major role in BP regulation at higher tem-
peratures but further experiments are needed to clarify how
this occurs.
In summary, the present ﬁndings indicate that P2X1
receptors play an important role in BP regulation although
purinergic vasoconstriction alone may not explain the
P2X1 receptor-mediated pressor responses in the anesthetized mouse 463potent pressor response to a,b-MeATP in the anesthetized
mouse.
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